Nektar Therapeutics
NKTR
$0.8968
$0.08149.98%
| Weiss Ratings | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.94 | |||
| Price History | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 4.53% | |||
| 30-Day Total Return | 5.43% | |||
| 60-Day Total Return | -11.21% | |||
| 90-Day Total Return | -24.64% | |||
| Year to Date Total Return | -6.68% | |||
| 1-Year Total Return | 4.28% | |||
| 2-Year Total Return | -25.27% | |||
| 3-Year Total Return | -78.44% | |||
| 5-Year Total Return | -93.80% | |||
| 52-Week High % Change | -57.71% | |||
| 52-Week Low % Change | 25.45% | |||
| Price | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.93 | |||
| 52-Week Low Price | $0.65 | |||
| 52-Week Low Price (Date) | Feb 11, 2025 | |||
| 52-Week High Price (Date) | May 13, 2024 | |||
| Valuation | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 150.41M | |||
| Enterprise Value | 75.65M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.84 | |||
| Earnings Per Share Growth | -46.18% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.83 | |||
| Price/Book (Q) | 3.08 | |||
| Enterprise Value/Revenue (TTM) | 0.81 | |||
| Price | $0.90 | |||
| Enterprise Value/EBITDA (TTM) | -0.58 | |||
| Enterprise Value/EBIT | -0.56 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 209.25M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 415 482 5300 | |||
| Address | 455 Mission Bay Boulevard South San Francisco, CA 94158 | |||
| Website | www.nektar.com | |||
| Country | United States | |||
| Year Founded | 1990 | |||
| Profitability | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -145.90% | |||
| Profit Margin | -180.70% | |||
| Management Effectiveness | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -22.64% | |||
| Return on Equity | -- | |||
| Income Statement | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 93.14M | |||
| Total Revenue (TTM) | 93.14M | |||
| Revenue Per Share | $0.45 | |||
| Gross Profit (TTM) | 63.15M | |||
| EBITDA (TTM) | -130.19M | |||
| EBIT (TTM) | -135.90M | |||
| Net Income (TTM) | -168.30M | |||
| Net Income Avl. to Common (TTM) | -168.30M | |||
| Total Revenue Growth (Q YOY) | -0.08% | |||
| Earnings Growth (Q YOY) | 19.15% | |||
| EPS Diluted (TTM) | -0.84 | |||
| EPS Diluted Growth (Q YOY) | 26.42% | |||
| Balance Sheet | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 244.50M | |||
| Cash Per Share (Q) | $1.17 | |||
| Total Current Assets (Q) | 286.48M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 48.88M | |||
| Current Ratio (Q) | 4.239 | |||
| Book Value Per Share (Q) | $0.27 | |||
| Total Assets (Q) | 307.97M | |||
| Total Current Liabilities (Q) | 67.58M | |||
| Total Debt (Q) | 206.09M | |||
| Total Liabilities (Q) | 259.08M | |||
| Total Common Equity (Q) | 48.88M | |||
| Cash Flow | NKTR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 99.74M | |||
| Cash from Financing (TTM) | 42.05M | |||
| Net Change in Cash (TTM) | -34.81M | |||
| Levered Free Cash Flow (TTM) | -74.54M | |||
| Cash from Operations (TTM) | -176.57M | |||
